Sponsored Links
| New Data For Cimzia® (Certolizumab Pegol) Showed A Rapid Clinical Response Across A Broad Population Of Rheumatoid Arthritis (RA) Patients |
 |
 |
 |
| Medical News - Arthritis and Rheumatology | |
|
UCB announced data which showed that the addition of Cimzia® (certolizumab pegol) to current therapy was associated with a rapid and consistent clinical response in a diverse group of rheumatoid arthritis (RA) patients... Read more: Arthritis / Rheumatology News From Medical News Today
|